Rchr
J-GLOBAL ID：200901010040896337
Update date: Apr. 21, 2024
YAMANAKA ATSUSHI
ヤマナカ アツシ | YAMANAKA ATSUSHI
Affiliation and department：
Research field (1)：
Virology
Papers (50)：
-
Yoshihiro Samune, Akatsuki Saito, Tadahiro Sasaki, Ritsuko Koketsu, Narinee Srimark, Juthamas Phadungsombat, Masaru Yokoyama, Osamu Kotani, Hironori Sato, Atsushi Yamanaka, et al. Genetic regions affecting the replication and pathogenicity of dengue virus type 2. PLoS neglected tropical diseases. 2024. 18. 1. e0011885
-
Rodolphe Hamel, Ronald Enrique Morales Vargas, Dora Murielle Rajonhson, Atsushi Yamanaka, Jiraporn Jaroenpool, Sineewanlaya Wichit, Dorothée Missé, Anamika Kritiyakan, Kittipong Chaisiri, Serge Morand, et al. Identification of the Tembusu Virus in Mosquitoes in Northern Thailand. Viruses. 2023. 15. 7
-
Rochanawan Sootichote, Wilarat Puangmanee, Surachet Benjathummarak, Siriporn Kowaboot, Atsushi Yamanaka, Korbporn Boonnak, Sumate Ampawong, Supawat Chatchen, Pongrama Ramasoota, Pannamthip Pitaksajjakul. Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections. Biomedicines. 2023. 11. 1
-
Atsushi Yamanaka, Pimploy Rattanaamnuaychai, Mami Matsuda, Ryosuke Suzuki, Jun Shimizu, Tatsuo Shioda, Kazuo Miyazaki. Development of a rapid assay system for detecting antibody-dependent enhancement of dengue virus infection. Journal of virological methods. 2023. 311. 114641-114641
-
Atsushi Yamanaka, Pimploy Rattanaamnuaychai, Mami Matsuda, Ryosuke Suzuki, Yoshiharu Matsuura, Masashi Tatsumi, Eiji Konishi. Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodies. Vaccine. 2022. 40. 42. 6004-6011
ｍore...
Lectures and oral presentations (1)：
-
Development of dengue vaccine antigens suppressing induction of infection-enhancing antibody by a single amino acid substitution
(The 28th Annual Medical Sciences Conference, 2020 2020)
Professional career (1)：
Return to Previous Page
